RAB13 and hepatocellular carcinoma: Moreover, a recent study suggests that knockdown of Rab13 inhibits HCC cell growth and metastasis through inhibiting the PI3K/AKT pathway, CDK1/CDK4 expression and EMT (Jacob et al. 2013).